Disturbances in sleep patterns increase the risk of depression in midlife women

FHS
July 4, 2024
10:38 am

The relationship between sleep-wake changes and depressive symptoms among midlife women.

ALX cuts two anti-CD47 programs just weeks after Gilead stopped a pivotal study of its own candidate

ALX Oncology is cutting two studies of its anti-CD47 drug evorpacept after it failed to show substantial efficacy. In its second-quarter report Thursday afternoon, ALX

August 12, 2023

In the case of a devastating disease, the FDA weighs an experimental drug’s muddled data and a desperate need

Emma Albee knows the experimental drug she takes is not a cure. It won’t allow her to stop using the wheelchair she’s relied on since

August 14, 2023

House committee investigates FDA’s handling of common nasal decongestant as efficacy questions loom

A House panel is probing the FDA over how it has allowed a common ingredient in over-the-counter cold medications to stay on the market for

December 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.